Results 141 to 150 of about 41,377 (182)

Ritonavir

Drugs, 1996
Ritonavir is a protease inhibitor with an HIV-1 resistance profile similar to that of indinavir, but different from that of saquinavir. Ritonavir has good oral bioavailability, and may increase the bioavailability of other protease inhibitors including saquinavir, nelfinavir, indinavir and VX-478.
A P, Lea, D, Faulds
  +6 more sources

Lopinavir/Ritonavir

Journal of the Association of Nurses in AIDS Care, 2001
Treatment Review is intended to inform and update nurses about treatments relevant to HIV/AIDS. Product information presented in this column does not imply endorsement by the Association of Nurses in AIDS Care.
openaire   +2 more sources

Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir

HIV Medicine, 2014
ObjectivesRitonavir‐boosted atazanavir and darunavir are protease inhibitors that are recommended for initial treatment of HIV infection because each has shown better lipid effects and overall tolerability than ritonavir‐boosted lopinavir. The extent to which lipid effects and overall tolerability differ between treatments with atazanavir and darunavir
Martinez, E, Gonzalez-Cordon, A, Ferrer, E, Domingo, P, Negredo, E, Gutierrez, F, Portilla, J, Curran, A, Podzamczer, D, Murillas, J, Bernardino, JI, Santos, I, Carton, JA, Peraire, J, Pich, J, Perez, I, Gatell, JM   +16 more
openaire   +4 more sources

Effects of Atazanavir/Ritonavir or Fosamprenavir/Ritonavir on the Pharmacokinetics of Rosuvastatin

Journal of Cardiovascular Pharmacology, 2008
Rosuvastatin (RSV) is a potent statin with a lower potential for drug interactions. However, recent data have revealed unexpected increases in RSV concentrations with lopinavir/ritonavir. The objective is to study the pharmacokinetic interaction of RSV with atazanavir/ritonavir (ATV/RTV) or fosamprenavir/ritonavir (FPV/RTV).In a prospective ...
Anthony J, Busti, Amy M, Bain, Ronald G, Hall, Roger G, Bedimo, Richard D, Leff, Claudia, Meek, Reza, Mehvar   +6 more
openaire   +2 more sources

Ritonavir

Reactions Weekly, 1999
  +6 more sources

Lopinavir/ritonavir/paclitaxel/ritonavir interaction

Reactions Weekly, 2022
openaire   +1 more source

Ritonavir

Reactions Weekly, 2011
  +4 more sources

[Ritonavir].

Enfermedades infecciosas y microbiologia clinica, 1997
  +8 more sources

Ritonavir

Reactions Weekly, 1998
  +5 more sources

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Clinical Microbiology and Infection, 2021
François Goehringer, Olivier Epaulard, Jean Reignier   +2 more
exaly